The growing body of investigations have reported that the CXCL12-CXCR4/CXCR7 signaling axis plays a crucial role in a variety of cancers, including leukemia, breast cancer, lung cancer, prostate cancer, MM, colorectal cancer, and bladder cancer. This evidence concerns the gene CXCR4 and prostate carcinoma.